Relationship of epidermal growth factor receptor gene mutations in exons 19 and 21 and clinicopathologic features in patients with non-small cell lung cancer (NSCLC) in ZhouShan Archipelago
Yongkui Zhang
Abstract
Yongkui Zhang
Abstract
Objective:To investigate epidermal growth factor receptor(EGFR) gene mutations in exons 19 and 21 of patients with non-small cell lung cancer(NSCLC) and to analyze the relationship of EGFR mutations with clinicopathologic features in Zhoushan Archipelago.Methods:The EGFR gene exons 19 and 21 of tumor tissue were amplified by PCR,followed by direct sequencing in 129 surgically-removed specimens of NSCLC.The relationship of EGFR gene mutations in NSCLC with clinicopathologic features and prognosis were analyzed.Results:EGFR mutations were detected in 35 cases of 129(27.1%) patients with NSCLC.Mutations were more frequently observed in women,non-smokers,adenocarcinoma patients and well-differentiated NSCLC patients,which were the risk factors for EGFR mutation(P 0.05).Kaplan-Meier survival analysis showed that the overall survival time of NSCLC patients with wild-type EGFR had no significant difference with patients with mutated EGFR(P 0.05).Conclusion:The rate of EGFR mutations occurred in Zhoushan Archipelago was 27.1%,more frequently in females,non-smokers,adenocarcinoma patients and well-differentiated NSCLC patients,but it had no significant correlation with overall survival time.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate epidermal growth factor receptor(EGFR) gene mutations in exons 19 and 21 of patients with non-small cell lung cancer(NSCLC) and to analyze the relationship of EGFR mutations with clinicopathologic features in Zhoushan Archipelago.Methods:The EGFR gene exons 19 and 21 of tumor tissue were amplified by PCR,followed by direct sequencing in 129 surgically-removed specimens of NSCLC.The relationship of EGFR gene mutations in NSCLC with clinicopathologic features and prognosis were analyzed.Results:EGFR mutations were detected in 35 cases of 129(27.1%) patients with NSCLC.Mutations were more frequently observed in women,non-smokers,adenocarcinoma patients and well-differentiated NSCLC patients,which were the risk factors for EGFR mutation(P 0.05).Kaplan-Meier survival analysis showed that the overall survival time of NSCLC patients with wild-type EGFR had no significant difference with patients with mutated EGFR(P 0.05).Conclusion:The rate of EGFR mutations occurred in Zhoushan Archipelago was 27.1%,more frequently in females,non-smokers,adenocarcinoma patients and well-differentiated NSCLC patients,but it had no significant correlation with overall survival time.
Key concepts: Epidermal growth factor receptor, Lung cancer, Exon, Adenocarcinoma, Internal medicine, Oncology, Mutation, Medicine